HomeCompareNUVA vs MAIN

NUVA vs MAIN: Dividend Comparison 2026

NUVA yields 5.03% · MAIN yields 6.91%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MAIN wins by $42.86M in total portfolio value
10 years
NUVA
NUVA
● Live price
5.03%
Share price
$39.75
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$27.8K
Annual income
$694.15
Full NUVA calculator →
MAIN
Main Street Capital Corporation
● Live price
6.91%
Share price
$52.96
Annual div
$3.66
5Y div CAGR
72.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$42.89M
Annual income
$35,818,348.00
Full MAIN calculator →

Portfolio growth — NUVA vs MAIN

📍 MAIN pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodNUVAMAIN
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, NUVA + MAIN cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
NUVA pays
MAIN pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

NUVA
Annual income on $10K today (after 15% tax)
$427.67/yr
After 10yr DRIP, annual income (after tax)
$590.03/yr
MAIN
Annual income on $10K today (after 15% tax)
$587.42/yr
After 10yr DRIP, annual income (after tax)
$30,445,595.80/yr
At 15% tax rate, MAIN beats the other by $30,445,005.77/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of NUVA + MAIN for your $10,000?

NUVA: 50%MAIN: 50%
100% MAIN50/50100% NUVA
Portfolio after 10yr
$21.46M
Annual income
$17,909,521.08/yr
Blended yield
83.47%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on NUVA right now

NUVA
Analyst Ratings
13
Buy
21
Hold
1
Sell
Consensus: Hold
Price Target
$58.00
+45.9% upside vs current
Range: $50.00 — $64.00
Altman Z
1.9
Piotroski
7/9
MAIN
Analyst Ratings
2
Buy
11
Hold
Consensus: Hold
Price Target
$65.25
+23.2% upside vs current
Range: $60.00 — $70.00
Altman Z
1.7
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

NUVA buys
0
MAIN buys
0
No recent congressional trades found for NUVA or MAIN in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricNUVAMAIN
Forward yield5.03%6.91%
Annual dividend / share$2.00$3.66
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%72.7%
Portfolio after 10y$27.8K$42.89M
Annual income after 10y$694.15$35,818,348.00
Total dividends collected$6.0K$41.85M
Payment frequencyquarterlymonthly
SectorStockBDC
Analyst consensusHoldHold
Analyst price target$58.00$65.25

Year-by-year: NUVA vs MAIN ($10,000, DRIP)

YearNUVA PortfolioNUVA Income/yrMAIN PortfolioMAIN Income/yrGap
1← crossover$11,203$503.14$12,434$1,193.51$1.2KMAIN
2$12,514$526.80$16,255$2,280.05$3.7KMAIN
3$13,940$549.96$22,851$4,580.08$8.9KMAIN
4$15,488$572.54$35,577$9,892.59$20.1KMAIN
5$17,167$594.52$63,653$23,664.70$46.5KMAIN
6$18,985$615.85$136,601$65,054.52$117.6KMAIN
7$20,950$636.49$368,044$214,504.02$347.1KMAIN
8$23,073$656.44$1,301,668$887,987.40$1.28MMAIN
9$25,364$675.66$6,288,483$4,825,407.47$6.26MMAIN
10$27,834$694.15$42,886,603$35,818,348.00$42.86MMAIN

NUVA vs MAIN: Complete Analysis 2026

NUVAStock

NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. It provides surgical access instruments, including Maxcess integrated split-blade retractor system that enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery; specialized spinal implants to advance spinal fusion by enhancing the osseointegration and biomechanical properties of implant materials, including porous titanium and porous polyetheretherketone; and fixation system that facilitates the preservation and restoration of patient alignment. The company also offers cervical total disc replacement technology for cervical spinal fusion surgery; neuromonitoring systems, which use proprietary software-driven nerve detection and avoidance technology, and its intraoperative neuromonitoring services and support; and Pulse platform, a software ecosystem that integrates multiple hardware technologies into a single, condensed footprint in the operating room. In addition, it provides expandable growing rod implant systems for the treatment of early-onset scoliosis; various biologics that are used to aid in the spinal fusion or bone healing process; Precice, an intramedullary implant device that utilizes the MAGEC technology to non-invasively lengthen the femur and tibia; and onsite and remote monitoring of the neurological systems of patients undergoing spinal and brain-related surgeries. The company sells its products to patients, surgeons, hospitals, and insurers through independent sales agents, directly employed sales personnel, and distributors in the United States and internationally. NuVasive, Inc. was incorporated in 1997 and is headquartered in San Diego, California.

Full NUVA Calculator →

MAINBDC

Main Street Capital Corporation is a business development company specializes in equity capital to lower middle market companies. The firm specializing in recapitalizations, management buyouts, refinancing, family estate planning, management buyouts, refinancing, industry consolidation, mature, later stage emerging growth. The firm also provides debt capital to middle market companies for acquisitions, management buyouts, growth financings, recapitalizations and refinancing. The firm seeks to partner with entrepreneurs, business owners and management teams and generally provides one stop financing alternatives within its lower middle market portfolio. It prefers to invest in air freight and logistics, auto components, building products, chemicals, commercial services, computers, construction and engineering, consumer finance, consumer services, electronic equipment, energy equipment and services, financial services, health care equipment, health care providers, hotels, restaurants, and leisure, internet software and services, IT Services, machinery, oil, gas and consumable fuels, paper and forest products, professional and industrial services, road and rail, software, specialty retail, telecommunication, consumer discretionary, energy, materials, technology, and transportation. The firm typically invests in lower middle market companies generally with annual revenues between $5 million and $300 million. It prefers to invest in ranging between $2 million and $75 million in equity investment and enterprise value in ranging between $3 million and $20 million. The firm typically prefers to invest in the range of $5 million and $50 million per transaction in debt investment value and in the range of $1 million and $20 million in annual EBITDA. The firm's middle market debt investments are made in businesses that are generally larger in size than its lower middle market portfolio companies. It takes 5 percent minority and up to 50 percent majority equity investments. Main Street Capital Corporation was founded in 2007 and is based in Houston, Texas with an additional office in Chojnów, Poland.

Full MAIN Calculator →
📬

Get this NUVA vs MAIN comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

NUVA vs SCHDNUVA vs JEPINUVA vs ONUVA vs KONUVA vs ARCCNUVA vs HTGCNUVA vs GBDCNUVA vs ORCC

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.